HealthyDirect · Growth
HDFC Pharma and Healthcare Fund
HDFC Mutual FundEquity Scheme - Sectoral/ Thematic3 years
The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.
- NAV
- 22.292
- 15 Sept 2026
- 1Y
- +25.3%
- Trailing CAGR
- AUM
- ₹3,310.64 Cr
- 31 Aug 2026
- Volatility
- Medium
- 14.0% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+25.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+31.4%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+37.1%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +31.4%
- Calendar-day CAGR
- Excess 1Y
- +19.3%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 7 days
- 63 recovered episodes
- Longest recovery
- 126 days
- Trough to prior peak
- Current spell
- 5 days
- Days below latest peak
- Time below peak
- +78%
- NAV observations
2 Jan 2025 – 4 Jul 2025
Trough 28 Feb 2025 · recovered in 126 days
-14.9%
30 Jul 2025 – 26 Feb 2026
Trough 2 Feb 2026 · recovered in 24 days
-7.8%
26 Feb 2026 – 22 Apr 2026
Trough 23 Mar 2026 · recovered in 30 days
-6.8%
23 Feb 2024 – 29 Apr 2024
Trough 13 Mar 2024 · recovered in 47 days
-5.8%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
79
Vs category
100
Consistency
97
Risk-adjusted
100
Drawdown
63
Mean
88
Portfolio
31 Aug 2026 · 40 holdings · top 10 are 48.9%.
- Top 5
- 30.7%
- Top 10
- 48.9%
- Largest holding
- 9.5%
- Effective holdings
- 25.4
Divi's Laboratories Ltd
Healthcare
9.5%
Sun Pharmaceutical Industries Ltd
Healthcare
8.9%
Torrent Pharmaceuticals Ltd
Healthcare
4.1%
Max Healthcare Institute Ltd
Healthcare
4.1%
Lupin Ltd
Healthcare
4.0%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 15 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 97% of rolling 1-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
- Peak-to-trough drawdown has stayed shallower than 15%.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
Kotak Business Cycle Fund
Kotak Mahindra Mutual Fund
- 1Y
- +2.5%
- 3Y
- +14.5%
- Vol
- 12.6%
- Max DD
- -18.4%
- Sharpe
- 0.82
- 3Y win
- +97%
- Lower volatility
- Higher win rate vs category
Caveat: Deeper drawdown · Lower trailing returns
Motilal Oswal Active Momentum Fund
Motilal Oswal Mutual Fund
- 1Y
- +25.5%
- 3Y
- n/a
- Vol
- 17.1%
- Max DD
- -16.6%
- Sharpe
- 1.25
- 3Y win
- n/a
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Baroda BNP Paribas Energy Opportunities Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +0.7%
- 3Y
- n/a
- Vol
- 13.8%
- Max DD
- -9.7%
- Sharpe
- 0.33
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Lower trailing returns
Sundaram Multi-Factor Fund
Sundaram Mutual Fund
- 1Y
- -5.2%
- 3Y
- n/a
- Vol
- 13.5%
- Max DD
- -14.9%
- Sharpe
- -0.59
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
Caveat: Lower trailing returns
Nippon India Innovation Fund
Nippon India Mutual Fund
- 1Y
- +0.2%
- 3Y
- +13.9%
- Vol
- 14.1%
- Max DD
- -21.5%
- Sharpe
- 0.68
- 3Y win
- +100%
- Higher win rate vs category
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns